Dysmenorrhea Treatment Market Value Projected to Expand by 2028

Dysmenorrhea Treatment Market is anticipated to grow at a considerable CAGR of 8.1% during the forecast period (2022-2028). Dysmenorrhea is a common gynaecological condition that affects women of all ages and races. It is one of the most commonly diagnosed causes of pelvic pain in women. The symptoms associated with dysmenorrhea include gastrointestinal symptoms such as diarrhoea, nausea, bloating, constipation, or both, along with vomiting and indigestion. According to the National Centre for Biotechnology Information the prevalence of dysmenorrhea can vary between 16% and 91% in women of reproductive age, with severe pain observed in 2% to 29%. Dysmenorrhea is associated with significant impairment in quality of life between 16% to 29% of women. Furthermore, 12% of the monthly school and work activities are lost due to absenteeism because of dysmenorrhea. 

To Request a Sample of our Report on Dysmenorrhea Treatment Market:  https://www.omrglobal.com/request-sample/dysmenorrhea-treatment-market

Rising acquisitions, product approval, collaborations among the major players in the market also propel the growth of the market. For instance, in May 2020, Mochida Pharmaceutical Co., Ltd announced the launch of DINAGEST Tablets 0.5 mg a therapeutic agent for dysmenorrhea. DINAGEST Tablets 1 mg, a therapeutic agent for endometriosis, was licensed from Jenapharm, a subsidiary of Bayer AG, and developed by Mochida. The drug is marketed in Japan since 2008 and an additional indication, reduction of pain caused by adenomyosis. 

Market Coverage

The market number available for - 2021-2028
Base year- 2021
Forecast period- 2022-2028

Segment Covered- 

By Treatment Type
By Type

Regions Covered

North America
Europe
Asia-Pacific
Rest of the World

Competitive Landscape- Novartis AG, Bayer AG, Abbott Laboratories, F. Hoffmann-La Roche Ltd. 

A full Report of Dysmenorrhea Treatment Market is Available @ https://www.omrglobal.com/industry-reports/dysmenorrhea-treatment-market

Dysmenorrhea Treatment Market Report by Segment

By Treatment Type.

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Hormonal Therapy 

By Type 

Primary Dysmenorrhea
Secondary Dysmenorrhea 

Dysmenorrhea Treatment Market Report by Region

North America

United States
Canada

Europe

UK
Germany
Spain
France
Italy
Rest of Europe

Asia-Pacific

India
China
Japan
South Korea
Rest of APAC

Rest of the World

Latin America 
Middle East & Africa

Company Profiles 

Bayer AG
Hoffmann-La Roche Ltd
SANOFI
Alvogen Iceland
Pfizer Inc.
ObsEva
Nobelpharma Co., Ltd
Color Seven Co., Ltd.
Sun Pharmaceutical Industries Limited
Beurer GmbH
Abbott Laboratories
Taj Pharmaceuticals Ltd
Myovant Sciences GmbH
AbbVie Inc.
Janssen Pharmaceuticals, Inc. 
At Lupin Inc.
Cumberland Pharmaceuticals Inc.
BioElectronics Corporation
GlaxoSmithKline plc.
Merck & Co., Inc.

Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

https://sportmsr.com/%d9%85%d9%86-%d8%a7%d9%84%d9%85%d8%aa%d9%88%d9%82%d8%b9-%d8%a3%d9%86-%d8%aa%d8%aa%d9%88%d8%b3%d8%b9-%d8%a7%d9%84%d9%82%d9%8a%d9%85%d8%a9-%d8%a7%d9%84%d8%b3%d9%88%d9%82%d9%8a%d8%a9-%d9%84%d9%84%d9%8a-2/
https://revistaeconomiasocial.com/2022/12/22/el-mercado-europeo-de-inhaladores-preventivos-sera-testigo-de-una-aceleracion-del-crecimiento-para-2028/
https://www.diario-ya.com/regionales/%e9%a0%90%e8%a8%88%e5%88%b0-2022-2028-%e5%b9%b4%e5%be%b7%e5%9c%8b%e9%a0%90%e9%98%b2%e6%80%a7%e5%90%b8%e5%85%a5%e5%99%a8%e5%b8%82%e5%a0%b4%e5%a2%9e%e9%95%b7%e7%8e%87%e4%bd%8e%e8%bf%b7/272806/
https://citytoday-hildesheim.de/index.php/2022/12/22/der-nordamerikanische-markt-fur-praventive-inhalatoren-soll-bis-2028-schnell-wachsen/
https://www.asiatimeskorea.com/news/2028%eb%85%84%ea%b9%8c%ec%a7%80-%ea%b8%89%ec%86%8d%ed%95%9c-%ec%84%b1%ec%9e%a5%ec%9d%84-%eb%b3%bc-%ec%98%81%ea%b5%ad-%ec%98%88%eb%b0%a9-%ed%9d%a1%ec%9e%85%ea%b8%b0-%ec%8b%9c%ec%9e%a5/195120/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

About Orion Market Research 
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.